ARTICLE | Company News
Novo Nordisk, Sun Pharmaceutical endocrine news
July 4, 2011 7:00 AM UTC
The U.S. sales of Prandin and PrandiMet amounted to about DKK1 billion ($178.9 million) in 2010. PrandiMet is a combination of repaglinide, a short-acting beta-cell stimulating meglitinide, and metfo...